ArticleTherapeutic advances in medical oncology2026
Impact of race/ethnicity and the presence of immune-related adverse events on outcomes for non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Robert Hsu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.